By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Thursday that its second-quarter revenues rose 19 percent, with double-digit increases for its systems and consumables sales.

The Austin, Texas-based maker of multiplex systems for research and diagnostics brought in total revenues of $33.2 million for the three months ended June 30, up 19 percent from $27.8 million for Q2 2009. It fell just short of analysts' consensus estimate of $33.6 million in revenues for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.